(Press-News.org) SAN DIEGO – People taking the blood pressure drugs called beta blockers may be less likely to have changes in the brain that can be signs of Alzheimer's disease and other types of dementia, according to a study released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013.
The study involved 774 elderly Japanese-American men who took part in the Honolulu-Asia Aging Study. Autopsies were performed on the men after their death. Of the 774 men, 610 had high blood pressure or were being treated with medication for high blood pressure. Among those who had been treated (about 350), 15 percent received only a beta blocker medication, 18 percent received a beta blocker plus one or more other medications, and the rest of the participants received other blood pressure drugs.
The study found that all types of blood pressure treatments were clearly better than no treatment. However, men who had received beta blockers as their only blood pressure medication had fewer abnormalities in their brains compared to those who had not been treated for their hypertension, or who had received other blood pressure medications. The brains of participants who had received beta blockers plus other medications showed an intermediate reduction in numbers of brain abnormalities.
These included two distinct types of brain lesion: those indicating Alzheimer's disease, and lesions called microinfarcts, usually attributed to tiny, multiple, unrecognized strokes. Study participants who had taken beta blockers alone or in combination with another blood pressure medication had significantly less shrinkage in their brains.
"With the number of people with Alzheimer's disease expected to grow significantly as our population ages, it is increasingly important to identify factors that could delay or prevent the disease," said study author Lon White, MD, of the Pacific Health Research and Education Institute in Honolulu. "These results are exciting, especially since beta blockers are a common treatment for high blood pressure."
Earlier research has shown that high blood pressure in midlife is a strong risk factor for dementia.
###
Learn more about dementia at http://www.aan.com/patients.
The study was supported by the National Institutes of Health.
The American Academy of Neurology, an association of more than 25,000 neurologists and neuroscience professionals, is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as Alzheimer's disease, stroke, migraine, multiple sclerosis, brain injury, Parkinson's disease and epilepsy.
For more information about the American Academy of Neurology, visit http://www.aan.com or find us on Facebook, Twitter, Google+ and YouTube.
Media Contacts:
Rachel Seroka, rseroka@aan.com, (612) 928-6129
Angela Babb, APR, ababb@aan.com, (612) 928-6102
Can blood pressure drugs reduce the risk of dementia?
2013-01-08
ELSE PRESS RELEASES FROM THIS DATE:
Many physicians often fulfill patient requests for brand-name drugs instead of equivalent generics
2013-01-08
More than a third of U.S. physicians responding to a national survey indicated they often or sometimes prescribed brand-name drugs when appropriate generic substitutes were available simply because patients requested the brand-name drug. Survey respondents who had marketing relationships with industry were more likely to fulfill such patient requests than were those without those relationships. The report from investigators at the Mongan Institute for Health Policy (MIHP) at Massachusetts General Hospital (MGH) will appear in JAMA Internal Medicine (formerly Archives ...
HPV-associated cancer incidence rates point to needed efforts to increase HPV vaccination coverage
2013-01-08
Despite the decline in cancer death rates in the U.S., there is an increase in incidence rates for cancers associated with human papillomavirus (HPV) infection and more efforts are needed to increase HPV vaccination coverage levels to prevent the occurrence of these cancers in the future according to a study published January 7 in the Journal of the National Cancer Institute.
The American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American Association of Central Cancer Registries (NAACCR) ...
Targeting hepatitis C treatment: The importance of interleukin (IL)-28
2013-01-08
A metanalysis published in BioMed Central's open access journal BMC Medicine has confirmed that polymorphisms (SNP) in the gene coding for interleukin-28 (IL28B) influence natural hepatitis C viral (HCV) clearance and response to pegylated interferon-α plus ribavirin (PEG-IFN/RBV). Information about IL28B genotype could be used to provide personalized medicine and target treatment options effectively.
Over 200 million people worldwide are chronically infected with hepatitis C virus (HCV) and about a quarter of these will go on to develop cirrhosis of the liver. Treatment ...
Songbird sings in 3D
2013-01-08
The question 'How do songbirds sing?' is addressed in a study published in BioMed Central's open access journal BMC Biology. High-field magnetic resonance imaging and micro-computed tomography have been used to construct stunning high resolution, 3D, images, as well as a data set "morphome" of the zebra finch (Taeniopygia guttata) vocal organ, the syrinx.
Like humans, songbirds learn their vocalizations by imitation. Since their songs are used for finding a mate and retaining territories, birdsong is very important for reproductive success.
The syrinx, located at the ...
How do songbirds sing? In 3D!
2013-01-08
January 8, 2013 – A multinational team of researchers made a significant step forward in trying to understand how birds produce their beautiful songs. "We used cutting-edge 3D imaging techniques to understand the complicated structure of the vocal organ of songbirds, the syrinx", says Dr. Coen Elemans, from the University of Southern Denmark, the senior author on the study. Elemans and his colleagues are publishing their findings January 8, 2013 in BioMed Central's open access journal BMC Biology.
Communicating with sounds is central to the life of most animals and they ...
Costly breast cancer screenings don't add up to better outcomes
2013-01-08
Even though Medicare spends over $1 billion per year on breast cancer screenings such as a mammography, there is no evidence that higher spending benefits older women, researchers at Yale School of Medicine found in a study published Online First by JAMA Internal Medicine, a JAMA Network publication.
Led by Cary Gross, M.D., associate professor of internal medicine at Yale School of Medicine and director of the Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center at Yale, the study sought to provide a comprehensive understanding of breast cancer ...
Giant fossil predator provides insights into the rise of modern marine ecosystem structures
2013-01-08
An international team of scientists has described a fossil marine predator measuring 8.6 meters in length (about 28 feet) recovered from the Nevada desert in 2010 as representing the first top predator in marine food chains feeding on prey similar to its own size. A paper with their description will appear the week of January 7, 2013 in the EE (early electronic) issue of Proceedings of the National Academy of Sciences.
Scientists who studied the fossil include lead author Dr. Nadia Fröbisch and Prof. Jörg Fröbisch (both at Museum für Naturkunde Leibniz-Institut für Evolutions- ...
Looming malpractice
2013-01-08
The average physician can expect to spend nearly 11 per cent of his or her career with a malpractice claim waiting to be resolved. Some specialists will spend nearly a third of their careers with open claims.
The length of time it takes to resolve a malpractice claim is a stress on patients, physicians and the legal system. The time spent with open claims may be even more distressing for physicians than the financial costs of malpractice claims.
"We believe that the time required to resolve malpractice claims may be a significant reason that physicians are so vocal ...
Centralization to fewer surgeons results in better survival after esophageal cancer surgery
2013-01-08
Patients who undergo surgery for oesophageal cancer have a much greater chance of long term survival if the operation is carried out by a surgeon who has performed this particular operation many times before. This according to a new, large-scale study conducted by researchers at Karolinska Institutet in Sweden, and published in the Journal of Clinical Oncology. In their article, the researchers conclude that oesophageal cancer surgery should be concentrated – or centralised – to fewer surgeons.
Surgery is the most widely established curative treatment for oesophageal ...
The reason we lose at games
2013-01-08
Writing in PNAS, a University of Manchester physicist has discovered that some games are simply impossible to fully learn, or too complex for the human mind to understand.
Dr Tobias Galla from The University of Manchester and Professor Doyne Farmer from Oxford University and the Santa Fe Institute, ran thousands of simulations of two-player games to see how human behaviour affects their decision-making.
In simple games with a small number of moves, such as Noughts and Crosses the optimal strategy is easy to guess, and the game quickly becomes uninteresting.
However, ...